Mesirow Financial Investment Management Inc. lessened its position in Colgate-Palmolive (NYSE:CL – Free Report) by 0.4% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 45,374 shares of the company’s stock after selling 173 shares during the period. Mesirow Financial Investment Management Inc.’s holdings in Colgate-Palmolive were worth $4,711,000 as of its most recent filing with the SEC.
Several other hedge funds also recently bought and sold shares of CL. Sustainable Insight Capital Management LLC increased its holdings in shares of Colgate-Palmolive by 104.8% in the third quarter. Sustainable Insight Capital Management LLC now owns 12,900 shares of the company’s stock worth $1,339,000 after acquiring an additional 6,600 shares in the last quarter. Essex Savings Bank increased its stake in Colgate-Palmolive by 28.6% during the 3rd quarter. Essex Savings Bank now owns 16,618 shares of the company’s stock worth $1,725,000 after purchasing an additional 3,694 shares in the last quarter. SpiderRock Advisors LLC increased its stake in Colgate-Palmolive by 1.2% during the 3rd quarter. SpiderRock Advisors LLC now owns 36,749 shares of the company’s stock worth $3,815,000 after purchasing an additional 437 shares in the last quarter. CWA Asset Management Group LLC acquired a new stake in Colgate-Palmolive during the 3rd quarter worth approximately $2,677,000. Finally, AEGON ASSET MANAGEMENT UK Plc lifted its stake in Colgate-Palmolive by 38.9% in the third quarter. AEGON ASSET MANAGEMENT UK Plc now owns 1,165,104 shares of the company’s stock valued at $120,913,000 after buying an additional 326,348 shares in the last quarter. 80.41% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analysts Forecast Growth
A number of equities research analysts recently commented on CL shares. TD Cowen dropped their price objective on shares of Colgate-Palmolive from $115.00 to $110.00 and set a “buy” rating on the stock in a report on Monday, October 28th. Stifel Nicolaus downgraded Colgate-Palmolive from a “buy” rating to a “hold” rating and dropped their price target for the company from $105.00 to $101.00 in a research note on Monday, October 28th. JPMorgan Chase & Co. upped their price objective on Colgate-Palmolive from $113.00 to $114.00 and gave the stock an “overweight” rating in a research report on Friday, October 11th. Wells Fargo & Company dropped their target price on Colgate-Palmolive from $100.00 to $92.00 and set an “underweight” rating on the stock in a research report on Monday, October 28th. Finally, Piper Sandler assumed coverage on Colgate-Palmolive in a research report on Tuesday, September 24th. They set an “overweight” rating and a $121.00 price target for the company. One analyst has rated the stock with a sell rating, nine have given a hold rating and thirteen have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $105.11.
Colgate-Palmolive Trading Up 2.0 %
CL stock opened at $92.57 on Monday. The stock has a market cap of $75.63 billion, a price-to-earnings ratio of 26.52, a price-to-earnings-growth ratio of 3.22 and a beta of 0.42. The company has a fifty day moving average price of $100.91 and a two-hundred day moving average price of $98.44. Colgate-Palmolive has a one year low of $74.67 and a one year high of $109.30. The company has a debt-to-equity ratio of 9.46, a current ratio of 1.04 and a quick ratio of 0.68.
Colgate-Palmolive Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Friday, November 15th. Shareholders of record on Friday, October 18th will be issued a $0.50 dividend. The ex-dividend date is Friday, October 18th. This represents a $2.00 annualized dividend and a yield of 2.16%. Colgate-Palmolive’s dividend payout ratio is currently 57.31%.
Insiders Place Their Bets
In other news, Director Martina Hundmejean sold 2,313 shares of the company’s stock in a transaction that occurred on Friday, August 23rd. The stock was sold at an average price of $103.86, for a total value of $240,228.18. Following the transaction, the director now owns 11,755 shares of the company’s stock, valued at approximately $1,220,874.30. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. In other news, CFO Stanley J. Sutula III sold 45,410 shares of Colgate-Palmolive stock in a transaction that occurred on Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total value of $4,273,535.10. Following the completion of the sale, the chief financial officer now directly owns 36,726 shares in the company, valued at approximately $3,456,283.86. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Martina Hundmejean sold 2,313 shares of the stock in a transaction that occurred on Friday, August 23rd. The stock was sold at an average price of $103.86, for a total value of $240,228.18. Following the sale, the director now directly owns 11,755 shares in the company, valued at $1,220,874.30. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 0.34% of the company’s stock.
About Colgate-Palmolive
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Recommended Stories
- Five stocks we like better than Colgate-Palmolive
- Most active stocks: Dollar volume vs share volume
- California Resources Stock Could Be a Huge Long-Term Winner
- Find and Profitably Trade Stocks at 52-Week Lows
- Observability Wars: Datadog and Dynatrace Vie for Data Dominance
- Are Penny Stocks a Good Fit for Your Portfolio?
- Airbnb Stock Attracts Attention With Strong Cash Flow Strategy
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL – Free Report).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.